DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

>10%: 

Dyskinesia 

1-10%: 

Constipation  

Increased blood creatine kinase  

Hypotension/syncope  

Decreased weight  

Hypertension  

Dry mouth  

Dizziness  

Hallucinations

 

 

 

Opicapone is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients. 

 

Pregnancy consideration:  

No data is available regarding the usage during pregnancy. 

Breastfeeding warnings:  

No data is available regarding the usage during lactation.  

Pregnancy category: 

• Category A: well-controlled and Satisfactory studies do not show risk to fetus in the first/later trimester.        
• Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women        
• Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.       
• Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.        
• Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.        
• Category N: There is no data available for the drug under this category 

 

 

 

 

Patient information leaflet 

Generic Name: opicapone 

Pronounced: oh-pik-a-pone 

Why do we use opicapone? 

Opicapone belongs to the category of antiparkinson agent. It helps treat Parkinson’s disease.